Basal cell carcinoma

Relevant risk variants from the literature

---

Population: Males of European ancestry

Locus	Chromo- some	Variant / SNP	My Codes	Relative Risk	Genotype frequency	Num. Cases / Num. Controls
1p36	1	rs7538876	AA	1.35	13.0%	2137 / 35921
Stacey, SN et al. Nat Genet. 2008 Nov;40(11):1313-8. Epub 2008 Oct 12.
1q42	1	rs801114	GT	1.06	45.5%	2145 / 35961
Stacey, SN et al. Nat Genet. 2008 Nov;40(11):1313-8. Epub 2008 Oct 12.
7q32	7	rs157935	GT	0.92	42.8%	3264 / 37807
Stacey, SN et al. Nat Genet. 2009 Jul 5.
CDKN2A/B	9	rs2151280	TT	0.83	24.0%	3412 / 38035
Stacey, SN et al. Nat Genet. 2009 Jul 5.
KRT5	12	rs11170164	GG	0.95	86.5%	3471 / 37915
Stacey, SN et al. Nat Genet. 2009 Jul 5.
TERT	5	rs401681	CC	1.20	31.4%	2565 / 29405
Rafnar, T et al. Nat Genet. 2009 Feb;41(2):221-7. Epub 2009 Jan 18.

Chromosome location of relevant variants

---

The figure below shows the genomic location of the relevant variants, represented as stripes across the chromosome. Their color indicates your relative risk (red: high risk, yellow: medium risk, green: low risk). Hover over the variants with the mouse cursor to obtain more detailed information.

Keep in mind

---

These are the results of calculations comparing your genetic sequence to sequence of participants in studies published in the world literature on genetic risk for this disease. Read more about how deCODEme calculates risks.

This test was developed and its performance characteristics determined by the deCODE genetics Diagnostic Laboratory. It has not been cleared or approved by the U. S. Food and Drug Administration (FDA).

Change history

---